利用共有HA序列构建广谱反应性流感H1抗原
研究从NCBI流感数据库下载截至2012年8月的2656条人H1N1病毒HA蛋白序列,构建系统发育树并生成共有H1蛋白CH1,进一步修饰已知保守T细胞和B细胞表位;CH1 DNA疫苗诱导广谱T细胞和B细胞反应但未中和pdm09 H1N1病毒,CH1与pdm09 HA联合DNA疫苗可中和pdm09 H1N1并保护小鼠免受所有代表性H1N1病毒致死感染;重组嵌合PR8-CH1病毒对小鼠高度减毒,LD50大于10^6 pfu,接种PR8-CH1病毒提供完全保护。
要点
- 共有H1蛋白CH1在遗传上与1980年代H1分离株A/Memphis/7/1980相似。
- CH1 DNA疫苗诱导广谱T细胞和B细胞反应,但未中和pdm09 H1N1病毒。
- CH1与pdm09 HA联合DNA疫苗可中和pdm09 H1N1并保护小鼠免受所有代表性H1N1病毒致死感染。
核心结论
- 通过构建共有HA序列开发了通用H1抗原CH1,含该共有序列的PR8-CH1病毒引发针对异源H1N1病毒的广谱保护性免疫。
研究设计与样本
- 研究下载截至2012年8月的2656条人H1N1病毒HA蛋白序列,使用MEGA 5.0软件通过邻接法构建系统发育树,生成共有H1蛋白CH1并修饰已发表的保守T细胞和B细胞表位;评估CH1 DNA疫苗、CH1与pdm09 HA联合DNA疫苗及重组PR8-CH1病毒在小鼠中的免疫原性和保护效果。
主要发现
- CH1蛋白在遗传上与1980年代H1分离株A/Memphis/7/1980相似。
- 表达CH1的DNA疫苗引发针对异源H1N1病毒的广谱T细胞和B细胞反应,但该疫苗未成功中和pdm09 H1N1病毒。
- CH1与pdm09 HA联合DNA疫苗接种中和pdm09 H1N1病毒,并保护小鼠免受所有代表性H1N1病毒的致死感染。
- 重组嵌合PR8-CH1病毒对小鼠高度减毒,半数致死量(LD50)大于10^6 pfu。
- 接种PR8-CH1病毒提供针对异源H1N1病毒感染的完全保护。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
H1N1, one of the most prevalent influenza A virus subtypes affecting the human population, can cause infections varying from mild respiratory syndrome to severe pneumonia. The current H1N1 vaccine needs to be updated annually and does not protect against future outbreaks. Here, we downloaded 2,656 HA protein sequences of human H1N1 viruses from the NCBI influenza database (up to the date of Aug. 2012) and constructed a phylogenetic tree of these H1 proteins via the neighbor-joining method using MEGA 5.0 software. A consensus H1 protein (CH1) was generated and was further modified with published conserved T-cell and B-cell epitopes. Interestingly, this CH1 protein is genetically similar to an H1 isolate obtained during the 1980s (A/Memphis/7/1980), indicating that a universal HA antigen may exist in nature. Vaccination with a DNA vaccine expressing CH1 elicited broadly reactive T-cell and B-cell responses to heterologous H1N1 viruses, though this vaccine did not successfully neutralize pdm09 H1N1 viruses. A combination of CH1 and pdm09 HA in a DNA vaccination neutralized pdm09 H1N1 viruses and protected mice from lethal infections by all representative H1N1 viruses. Moreover, a recombinant chimeric PR8-CH1 virus carrying HA sequence of the consensus H1 and all other seven genes from the PR8 strain was highly attenuated in mice, with a lethal dose (LD50) of more than 106 pfu. Vaccination with PR8-CH1 virus provided complete protection against infections by heterologous H1N1 strains. Taken together, a universal H1 antigen, CH1, was developed by constructing a consensus HA sequence, and the PR8-CH1 virus containing this consensus sequence elicited broadly protective immunity against heterologous H1N1 viruses.
引用
- Ping X, Hu W, Xiong R, et al. Generation of a broadly reactive influenza H1 antigen using a consensus HA sequence. Vaccine. 2018. PMID: 29960799. doi:10.1016/j.vaccine.2018.06.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。